Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300103
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,167
Award facts
- Contract value 100% obligated
- $3,166.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$84 | |
| Original award | $3,250 |
Quick answers
Who was awarded contract HHSN26300103?
HHSN26300103 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on August 6, 2015.
How much is contract HHSN26300103 worth?
The government has obligated $3,167 on HHSN26300103.
Is contract HHSN26300103 an order under another contract?
Yes. HHSN26300103 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300103 competed?
The extent of competition for HHSN26300103 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award